| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 4 Feb 25 | CTMX CytomX Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 57,500 | 0.00 | 139,750 |
| 4 Feb 25 | CTMX CytomX Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 56,000 | 0.00 | 82,250 |
| 4 Feb 25 | CTMX CytomX Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.864 | 115,000 | 99.36 k | 115,000 |
| 4 Feb 25 | CTMX CytomX Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.864 | 238,000 | 205.63 k | 238,000 |
| 18 Jan 24 | CTMX CytomX Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 26,250 | 0.00 | 26,250 |
| 18 Jan 24 | CTMX CytomX Therapeutics | Performance Stock Units (PSUs) Common Stock | Grant | Acquire A | No | No | 0 | 75,000 | 0.00 | 75,000 |
| 18 Jan 24 | CTMX CytomX Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.68 | 122,500 | 205.80 k | 122,500 |
